Literature DB >> 17056074

Alkylene tether-length dependent gamma-aminobutyric acid type A receptor competitive antagonism by tacrine dimers.

Chaoying Li1, Paul R Carlier, Hong Ren, Kelvin K W Kan, Kwokmin Hui, Hong Wang, Wenming Li, Zhiwang Li, Keming Xiong, Ella Chow Clement, Hong Xue, Xiangou Liu, Mingtao Li, Yuanping Pang, Yifan Han.   

Abstract

Bis(7)-tacrine was previously demonstrated as an antagonist of gamma-aminobutyric acid type A (GABA(A)) receptors. In this study, the effects of a series of alkylene-linked tacrine dimers on GABA(A) receptors were examined. In radioligand binding assay, the analogues differed in binding affinity for GABA(A) receptors, and potency monotonically increased as the tether was shortened from nine to two methylenes. Bis(2)-tacrine, the shortest tacrine dimer, could displace [(3)H]muscimol from rat brain membranes with an IC(50) of 0.48 microM, which was 11, 13 and 525 times more potent than the GABA(A) receptor antagonist (+)-bicuculline, bis(7)-tacrine and tacrine, respectively. In whole-cell patch-clamp recordings, these dimeric tacrine analogues competitively antagonized GABA-induced inward current with a rank order of potency of bis(2)-tacrine>bicuculline>bis(7)-tacrine>bis(9)-tacrine>tacrine, and the potency of bis(2)-tacrine was 11, 18 and 487 times higher than that of (+)-bicuculline, bis(7)-tacrine and tacrine, respectively. Bis(2)-tacrine shifted the GABA concentration-response curve to the right in a parallel manner, and the inhibition was voltage-independent between -80 and +20 mV. It can be concluded that the shorter the alkylene linkage in tacrine dimers the stronger the binding affinity and higher the antagonistic effect on the GABA(A) receptor will be.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056074     DOI: 10.1016/j.neuropharm.2006.07.039

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

Review 1.  An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.

Authors:  Xiaoling Zhou; Yifei Li; Xiaozhe Shi; Chun Ma
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice.

Authors:  Huixin Chen; Siying Xiang; Ling Huang; Jiajia Lin; Shengquan Hu; Shing-Hung Mak; Chuang Wang; Qinwen Wang; Wei Cui; Yifan Han
Journal:  Metab Brain Dis       Date:  2018-03-21       Impact factor: 3.584

3.  Pathologically activated neuroprotection via uncompetitive blockade of N-methyl-D-aspartate receptors with fast off-rate by novel multifunctional dimer bis(propyl)-cognitin.

Authors:  Jialie Luo; Wenming Li; Yuming Zhao; Hongjun Fu; Dik-Lung Ma; Jing Tang; Chaoying Li; Robert W Peoples; Fushun Li; Qinwen Wang; Pingbo Huang; Jun Xia; Yuanping Pang; Yifan Han
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

4.  Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors.

Authors:  Barbora Svobodova; Eva Mezeiova; Vendula Hepnarova; Martina Hrabinova; Lubica Muckova; Tereza Kobrlova; Daniel Jun; Ondrej Soukup; María Luisa Jimeno; José Marco-Contelles; Jan Korabecny
Journal:  Biomolecules       Date:  2019-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.